# US 2008/0287465 A1 · Cyclic N-Hydroxy Imides as Inhibitors of Flap Endonuclease and Uses Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0287465 A1
- Document ID: US20080287465A1
- Status: Published application
- Kind: A1
- Application number: 11/632,920
- Filed: 2005-07-20
- Published: 2008-11-20
- Earliest claimed: 2004-07-21
- Assignees: Athersys, Inc.
- Inventors: Lawrence N. Tumey; Youssef Bennani; Bayard Huck; David C. Bom
- Web page: https://patentgrep.com/patent/US20080287465A1

## CPC

- C07D 495/04: Ortho-condensed systems
- C07D 491/048: the oxygen-containing ring being five-membered
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Acrylic n-hydroxy imides and their use in pharmaceutical compositions and in the inhibition of flap endonuclease are disclosed.

## Claims

### Claim 1

A compound of the formula
where X and Y may be C, O or S provided that one of X and Y must be C;
R1 which is present when X is C is selected from the group consisting of H, aryl, heteroaryl, alkyl, alkylaryl, fused aryl with R2, and fused cycloalkyl with R2;
R2 is selected from the group consisting of H, aryl, heteroaryl, alkyl, alkylaryl, fused aryl with R1 or R3, and fused cycloalkyl with R1 or R3;
R3 which is present when Y is C is selected from the group consisting of H, aryl, heteroaryl, alkyl, alkylaryl, fused aryl with R2, and fused cycloalkyl with R2; and
R4 is selected from the group consisting of alkyl, aryl, heteroaryl and alkylaryl; and the pharmaceutically acceptable salts and isomers thereof.

### Claim 2 (depends on 1)

A compound as in claim 1 of the formula
where R1 is H, alkyl, aryl or a fused aryl or alkyl ring with R2;
R2 is H, alkyl, aryl, or a fused aryl or alkyl ring with R1;
R3 is alkyl or aryl; and
X is S or O; and

### Claim 3 (depends on 1)

A compound as I claim 1 of the formula
where R1 is H, alkyl, aryl or a fused aryl or alkyl ring with R2;
R2 is H, alkyl, aryl or a fused aryl or alkyl ring with R1;
R3 is alkyl or aryl; and
X is S or O.

### Claim 4 (depends on 1)

A compound as in claim 1 wherein X is C, Y is S, R1 is CH3, R2 is H, and R4 is substituted benzyl.

### Claim 5 (depends on 1)

A compound as in claim 1 selected from the group consisting of
3-Hydroxy-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-1,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulene-2,4-dione;
1-Benzyl-3-hydroxy-5-methyl-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(7-methoxy-benzo[1,3]dioxol-5-ylmethyl)-5-methyl-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-5-methyl-1-(2,4,5-trimethoxy-benzyl)-1H-thieno[2,3-d]pyrimidine;
1-(6-Chloro-pyridin-3-ylmethyl)-3-hydroxy-5-methyl-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-5-methyl-1-quinolin-2-ylmethyl-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-5-methyl-1-(2-thiophen-2-yl-thiazol-4-ylmethyl)-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-1-naphthalen-2-ylmethyl-1H-thieno[2,3-d]pyrimidine-2,4-dione;
3-Hydroxy-6-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-6-phenyl-1-(tetrahydro-furan-2-ylmethyl)-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-7-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
1-(3-Bromo-benzyl)-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-naphthalen-2-ylmethyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
1-(2-Chloro-benzyl)-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3′-(3-Hydroxy-2,4-dioxo-3,4-dihydro-2H-thieno[3,2-d]pyrimidin-1-ylmethyl)-biphenyl-4-carboxylic acid amide;
1-(3′-Acetyl-biphenyl-3-ylmethyl)-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
N-[3′-(3-Hydroxy-2,4-dioxo-3,4-dihydro-2H-thieno[3,2-d]pyrimidin-1-ylmethyl)-biphenyl-3-yl]-acetamide;
1-(6-Chloro-pyridin-3-ylmethyl)-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-[6-(4-trifluoromethoxy-phenyl)-pyridin-3-ylmethyl]-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-[6-(2-trifluoromethyl-phenyl)-pyridin-3-ylmethyl]-1H-thieno[3,2-d]pyrimidine-2,4-dione;
1-[6-(3,3-Dimethyl-but-1-enyl)-pyridin-3-ylmethyl]-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(2-pyrrolidin-1-yl-ethyl)-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-7-methyl-1-(4-methyl-benzyl)-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-7-methyl-1-(3-methyl-benzyl)-1H-thieno[3,2-d]pyrimidine-2,4-dione;
1-(4-Bromo-benzyl)-3-hydroxy-7-methyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
1-(2′-Acetyl-biphenyl-4-ylmethyl)-3-hydroxy-7-methyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
5-(4-Bromo-phenyl)-3-hydroxy-1H-thieno[2,3-d]pyrimidine-2,4-dione;
7-Benzenesulfonyl-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-7-phenyl-6-trifluoromethyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(4-methoxy-benzyl)-7-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(4-methoxy-benzyl)-7-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
1-(6-Chloro-pyridin-3-ylmethyl)-3-hydroxy-7-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
-Hydroxy-7-phenyl-1-(3,4,5-trimethoxy-benzyl)-1H-thieno[3,2-d]pyrimidine-2,4-dione'
3-Hydroxy-7-phenyl-1 thiophen-3-ylmethyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(4-methoxy-benzyl)-1,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulene-2,4-dione;
3-Hydroxy-1-thiophen-3-ylmethyl-1,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulene-2,4-dione;
1-(6-Chloro-pyridin-3-ylmethyl)-3-hydroxy-1,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulene-2,4-dione;
3-Hydroxy-1-methyl-1,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulene-2,4-dione;
6-tert-Butyl-3-hydroxy-1-(3-methoxy-benzyl)-1H-thieno[3,2-d]pyrimidine-2,4-dione;
6-tert-Butyl-3-hydroxy-1-naphthalen-2-ylmethyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
6-tert-Butyl-3-hydroxy-1-thiophen-3-ylmethyl-1H-thieno[3,2-d]pyrimidine-2,4-dione;
6-tert-Butyl-3-hydroxy-1H-thieno[3,2-d]pyrimidine-2,4-dione;
5-[6-(4-Chloro-phenyl)-3-hydroxy-2,4-dioxo-3,4-dihydro-2H-thieno[3,2-d]pyrimidin-1-ylmethyl]-furan-2-carboxylic acid methyl ester;
3-Hydroxy-1-methyl-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-Benzyl-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(1-phenyl-ethyl)-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-(4-tert-Butyl-benzyl)-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-propyl-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione and 3-Hydroxy-2-propoxy-3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-one;
1-Butyl-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione and 2-Butoxy-3-hydroxy-3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-one;
1-(3-Bromo-benzyl)-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-Biphenyl-2-ylmethyl-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
5-(3-Hydroxy-2,4-dioxo-3,4-dihydro-2H-benzo[4,5]thieno[3,2-d]pyrimidin-1-ylmethyl)-furan-2-carboxylic acid methyl ester;
3-Hydroxy-1-phenethyl-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(3-phenyl-allyl)-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-pyridin-2-ylmethyl-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-(4-Bromo-benzyl)-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-(2-Bromo-benzyl)-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-Biphenyl-3-ylmethyl-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-(4′-Acetyl-biphenyl-4-ylmethyl)-3-hydroxy-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-8-nitro-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-Benzyl-3-hydroxy-8-nitro-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
1-Biphenyl-2-ylmethyl-3-hydroxy-8-nitro-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-7-(3-methoxy-phenyl)-1H-furo[3,2-d]pyrimidine-2,4-dione;
7-Biphenyl-4-yl-3-hydroxy-1H-furo[3,2-d]pyrimidine-2,4-dione;
7-Biphenyl-4-yl-3-hydroxy-1H-furo[3,2-d]pyrimidine-2,4-dione;
1-Benzyl-7-(3-bromo-phenyl)-3-hydroxy-1H-furo[3,2-d]pyrimidine-2,4-dione;
1-Benzyl-7-(3-bromo-phenyl)-3-hydroxy-1H-furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(4-methoxy-benzyl)-7-(3-methoxy-phenyl)-1H-furo[3,2-d]pyrimidine-2,4-dione;
7-Benzyl-3-hydroxy-1H-furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(4-methoxy-benzyl)-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(2-methyl-thiazol-4-ylmethyl)-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(2-methyl-thiazol-4-ylmethyl)-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-Biphenyl-2-ylmethyl-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-prop-2-ynyl-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-Allyl-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(1-phenyl-ethyl)-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
3-Hydroxy-1-(3-phenyl-allyl)-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-(2-Bromo-benzyl)-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-(3-Bromo-benzyl)-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-(4-Bromo-benzyl)-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-(2,5-Difluorobiphenyl)-2-ylmethyl-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
1-(3-Benzo[1,3]dioxol-5-yl-benzyl)-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione;
4′-(3-Hydroxy-2,4-dioxo-3,4-dihydro-2H-benzo[4,5]furo[3,2-d]pyrimidin-1-ylmethyl)-biphenyl-3-carboxylic acid amide;
7-Diethylamino-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione; and
1-Benzyl-7-diethylamino-3-hydroxy-1H-benzo[4,5]furo[3,2-d]pyrimidine-2,4-dione.

### Claim 6 (depends on 1)

A pharmaceutical composition comprising at least one compound of claim 1 in combination with a pharmaceutically acceptable carrier.

### Claim 7 (depends on 1)

A method of treating a patient having a condition in which the inhibition of flap endonuclease is of therapeutic importance comprising administering a therapeutically effective amount of a compound of claim 1 to a patient in need of such treatment.
